A randomized controlled trial to assess the impact of prophylactic proton pump inhibitor use to improve esophagitis in lung cancer patients undergoing radiation. Patients will be randomized into a standard of care arm or the prophylactic proton pump (daily) arm.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
58
The intervention uses a proton pump inhibitor as a preventative measure
London Health Sciences Centre
London, Ontario, Canada
Worst patient-reported esophageal pain score during radiation
Assessed with the 11-Numeric Rating Scale using weekly questionnaires
Time frame: baseline last week of radiation post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.